Scholarlink

<p>Multidrug resistance and the acidic tumor microenvironment (TME) of malignant melanoma significantly limit the efficacy of conventional therapies. In this study, we constructed a near-infrared (NIR)-responsive thermosensitive phase-transition core–shell nanosystem (CaO-DOX-IR820@DLTP). This nanosystem uses CaO as the core, co-loading the chemotherapeutic drug doxorubicin (DOX) and the photothermal agent IR820, with a thermosensitive DLTP polymer shell as the outer layer. Characterization results show that the nanosystem has a uniform particle size, good stability, and excellent biocompatibility. Under NIR irradiation, the hyperthermia generated by IR820 induces phase transition and melting of the DLTP shell, enabling controlled release of DOX. Meanwhile, CaO reacts with water in the TME to trigger a chain exothermic reaction, enhancing photothermal therapeutic efficacy. The resulting Ca (OH)₂ effectively neutralizes lactic acid in the TME, thereby inhibiting M2 polarization of tumor-associated macrophages (TAMs) and alleviating lactate-mediated immunosuppression. Both in vitro and in vivo experimental results demonstrate that the nanosystem exhibits favorable tumor cell-killing effects, providing a novel strategy for the treatment of malignant melanoma.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

NIR-activated phase-transition thermal-propagation nanosystem for precision photothermal eradication of malignant melanoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月26日

查看全文
  • Xin Wang,
  • Purui Liu,
  • Chuanxi Cao,
  • Qinhan Yan,
  • Ruoshan Qin,
  • Dengqi He

摘要

Multidrug resistance and the acidic tumor microenvironment (TME) of malignant melanoma significantly limit the efficacy of conventional therapies. In this study, we constructed a near-infrared (NIR)-responsive thermosensitive phase-transition core–shell nanosystem (CaO-DOX-IR820@DLTP). This nanosystem uses CaO as the core, co-loading the chemotherapeutic drug doxorubicin (DOX) and the photothermal agent IR820, with a thermosensitive DLTP polymer shell as the outer layer. Characterization results show that the nanosystem has a uniform particle size, good stability, and excellent biocompatibility. Under NIR irradiation, the hyperthermia generated by IR820 induces phase transition and melting of the DLTP shell, enabling controlled release of DOX. Meanwhile, CaO reacts with water in the TME to trigger a chain exothermic reaction, enhancing photothermal therapeutic efficacy. The resulting Ca (OH)₂ effectively neutralizes lactic acid in the TME, thereby inhibiting M2 polarization of tumor-associated macrophages (TAMs) and alleviating lactate-mediated immunosuppression. Both in vitro and in vivo experimental results demonstrate that the nanosystem exhibits favorable tumor cell-killing effects, providing a novel strategy for the treatment of malignant melanoma.

Graphical Abstract